Ex vivo expansion of megakaryocyte progenitor cells: Cord blood versus mobilized peripheral blood

Stem Cells and Development

Volumn 14, Issue 4, 2005, Pages 415-424

  De Bruyn, Cecile ^a   Delforge, A ^a   Martiat, P ^a   Bron, D ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FIBRINOGEN RECEPTOR; FLT3 LIGAND; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; THROMBOPOIETIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; EX VIVO STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MEGAKARYOCYTE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLOIDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STEM CELL MOBILIZATION; STROMA CELL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TISSUE EXPANSION;

ANTIGENS, CD34; BLOOD CELLS; BLOOD PLATELETS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSPLANTATION; DNA; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-11; INTERLEUKIN-3; INTERLEUKIN-6; LEUKOCYTES; MEGAKARYOCYTES; MEMBRANE PROTEINS; PHENOTYPE; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET MEMBRANE GLYCOPROTEIN IIB; PLOIDIES; STEM CELL FACTOR; STEM CELLS; THROMBOPOIETIN; TIME FACTORS;

EID: 24144444671     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2005.14.415     Document Type: Article

References (60)

1. Rubinstein P, C Carrier, A Scaradavou, J Kurtzberg, J Adamson, AR Migliaccio, RL Berkowitz, M Cabbad, NL Dobrila, PE Taylor, RE Rosenfield, and CE Stevens. (1998). Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339:1565-1577.
2. Gluckman E. (2000). Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 28:1197-1205.
3. Bachier CR, E Gokmen, J Teale, S Lanzkron, C Childs, W Franklin, E Shpall, J Douville, S Weber, T Muller, D Armstrong, and CF LeMaistre. (1999). Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer. Exp Hematol 27:615-623.
4. McNiece I, R Jones, SI Bearman, P Cagnoni, Y Nieto, W Franklin, J Ryder, A Steele, J Stoltz, P Russell, J McDermitt, C Hogan, J Murphy, and EJ Shpall. (2000). Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 96:3001-3007.
5. Paquette RL, ST Dergham, E Karpf, HJ Wang, DJ Slamon, L Souza, and JA Glaspy. (2002). Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery. Exp Hematol 30:374-380.
6. Drayer AL, CT Sibinga, NR Blom, JT De Wolf, and E Vellenga. (2000). The in vitro effects of cytokines on expansion and migration of megakaryocyte progenitors. Br J Haematol 109:776-784.
7. + cells. Ann Hematol 79:13-19.
8. Piacibello W, L Garetto, and M Aglietta. (2000). Ex vivo expansion of megakaryocytes. Transfusion Sci 22:107-110.
9. Blair A, CL Baker, DH Pamphilon, and PA Judson. (2002). Ex vivo expansion of megakaryocyte progenitor cells from normal bone marrow and peripheral blood and from patients with haematological malignancies. Br J Haematol 116:912-919.
10. Pick M, A Eldor, D Grisani, AR Zander, M Shenhav, and VR Deutsch. (2002). Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood. A potential source of megakaryocytes for transplantation. Exp Hematol 30:1079-1087.
11. Woo SY, JH Kie, KH Ryu, HS Moon, WS Chung, DH Hwang, SK Kim, TH Han, MJ Hahn, YH Chong, HK Park, and JY Seoh. (2002). Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. Scand J Immunol 55:88-95.
12. Bruno S, M Gunetti, L Gammaitoni, A Dane, G Cavalloni, F Sanavio, F Fagioli, M Aglietta, and W Piacibello. (2003). In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution. Haematologica 88:379-387.
13. Bruno S, M Gunetti, L Gammaitoni, E Perissinotto, L Caione, F Sanavio, F Fagioli, M Aglietta, and W Piacibello. (2004). Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells. Stem Cells 22:135-143.
14. Bertolini F, M Battaglia, P Pedrazzoli, GA Da Prada, A Lanza, D Soligo, L Caneva, B Sarina, S Murphy, T Thomas, and GR della Cuna. (1997). Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 89:2679-2688.
15. Reiffers J, C Cailliot, B Dazey, M Altal, J Caraux, and JM Boiron. (1999). Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 354:1092-1093.
16. Paquette RL, ST Dergham, E Karpf, HJ Wang, DJ Slamon, L Souza, and JA Glaspy. (2000). Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 96:2385-2390.
17. Drayer AL, CT Smit Sibinga, MT Esselink, JT de Wolf, and E Vellenga. (2002). In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation. Ann Hematol 81:192-197.
18. Maurer AM, Y Liu, JP Caen, and ZC Han. (2000). Ex vivo expansion of megakaryocytic cells. Int J Hematol 71:203-210.
19. Shpall EJ, R Quinones, R Giller, C Zeng, AE Baron, RB Jones, SI Bearman, Y Nieto, B Freed, N Madinger, CJ Hogan, V Slat-Vasquez, P Russell, B Blunk, D Schissel, E Hild, J Malcolm, W Ward, and IK McNiece. (2002). Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transpl 8:368-376.
20. Jaroscak J, K Goltry, A Smith, B Waters-Pick, PL Martin, TA Driscoll, R Howrey, N Chao, J Douville, S Burhop, P Fu, and J Kurtzberg. (2003). Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the Aastrom-Replicell System. Blood 101:5061-5067.
21. Devine SM, HM Lazarus, and SG Emerson. (2003). Clinical application of hematopoietic progenitor cell expansion: current status and future prospects. Bone Marrow Transplant 31:241-252.
22. Scheding S, M Bergmannn, G Rathke, W Vogel, W Brugger, and L Kanz. (2004). Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy. Haematologica 89:630-631.
23. de Sauvage FJ, PE Hass, SD Spencer, BE Malloy, AL Gurney, SA Spencer, WC Darbonne, WJ Henzel, SC Wong, WJ Kuang, et al. (1994). Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533-538.
24. Lok S and DC Foster. (1994). The structure, biology and potential therapeutic applications of recombinant thrombopoietin. Stem Cells 12:586-598.
25. Bartley TD, J Bogenberger, P Hunt, YS Li, HS Lu, F Martin, MS Chang, B Samal, JL Nichol, S Swift, et al. (1994). Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117-1124.
26. Broudy VC and K Kaushansky. (1995). Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production. J Leukoc Biol 57:719-725.
27. Zeigler FC, F de Sauvage, HR Widmer, GA Keller, C Donahue, RD Schreiber, B Malloy, P Hass, D Eaton, and W Matthews. (1994), In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84:4045-4052.
28. Hunt P. (1995). The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis. Stem Cells 13:579-587.
29. Choi ES, JL Nichol, MM Hokom, AC Hornkohl, and P Hunt. (1995). Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85:402-413.
30. Choi ES, MM Hokom, JL Chen, J Skrine, J Faust, J Nichol, and P Hunt. (1996). The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Br J Haematol 95:227-233.
31. Oda A, Y Miyakawa, BJ Druker, K Ozaki, K Yabusaki, Y Shirasawa, M Handa, T Kato, H Miyazaki, A Shimosaka, and Y Ikeda. (1996). Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 87:4664-4670.
32. Ku H, Y Yonemura, K Kaushansky, and M Ogawa. (1996). Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87:4544-4551.
33. Williams JL, GG Pipia, NS Datta, and MW Long. (1998). Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood 91:4118-4126.
34. Dolzhanskiy A, J Hirst, RS Basch, and S Karpatkin. (1998). Complementary and antagonistic effects of IL-3 in the early development of human megakaryocytes in culture. Br J Haematol 100:415-426.
35. Lazzari L, R Henschler, L Lecchi, P Rebulla, R Mertelsmann, and G Sirchia. (2000). Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells. Haematologica 85:25-30.
36. Li K, M Yang, AC Lam, FW Yau, and PM Yuen. (2000). Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors. Cell Transplant 9:125-131.
37. + cells from cord blood. Haematologica 88:388-395.
38. Lepage A, M Leboeuf, JP Cazenave, C de la Salle, F Lanza, and G Uzan. (2000). The alpha(IIb)beta(3) integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34(+) cord blood cells to megakaryocytes. Blood 96:4169-4177.
39. Zimmet J and K Ravid. (2000). Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Exp Hematol 28:3-16.
40. Mattia G, F Vulcano, L Milazzo, A Barca, G Macioce, A Giampaolo, and HJ Hassan. (2002). Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 99:888-897.
41. van den Oudenrijn S, AE von dem Borne, and M de Haas. (2000). Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol 28:1054-1061
42. Schipper LF, A Brand, N Renters, CJ Melief, R Willemze, and WE Fibbe. (2003). Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol 31:324-330
43. Yasui K, K Matsumoto, F Hirayama, Y Tani, and T Nakano. (2003). Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation. Stem Cells 21:143-151.
44. Bornstein R, J Garcia-Vela, F Gilsanz, C Auray, and C Cales. (2001). Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. Br J Haematol 114:458-465.
45. Davey S, S Armitage, V Rocha, F Gamier, J Brown, CJ Brown, R Warwick, D Fehily, S Watt, E Gluckman, A Vora, M Contreras, and CV Navarrete. (2004). The London Cord Blood Bank: analysis of banking and transplantation outcome. Br J Haematol 125:358-365.
46. Basser R. (2004). Clinical biology and potential use of thrombopoietin. Can J Gastroenterol 14:73D-78D.
47. Bolwell B, J Vredenburgh, B Overmoyer, C Gilbert, L Chap, DM Menchaca, S Cruickshank, and J Glaspy. (2000). Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation. Bone Marrow Transplant 26:141-145.
48. Fields KK, M Crump, I Bence-Bruckler, S Bernstein, S Williams, S Frankel, A Miller, G Demetri, JM Nabholtz, S Cruickshank, and M Lill. (2000). Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation. Bone Marrow Transplant 26:1083-1088.
49. Kratz-Albers K, S Scheding, R Mohle, HJ Buhring, CM Baum, JP McKearn, T Buchner, L Kanz, and W Brugger. (2000). Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin. Exp Hematol 28:335-346.
50. + cells in collagen and liquid culture media. J Hematother 10:391-403.
51. Kie JH, WI Yang, MK Lee, TJ Kwon, YH Min, HO Kim, HS Ahn, SA Im, HL Kim, HY Park, KH Ryu, WS Chung, MH Shin, YJ Jung, SY Woo, HK Park, and JY Seoh. (2002). Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. Stem Cells 20:73-79.
52. Sato T, M Ono, H Fujita, N Tanaka, J Tomiyama, Y Sakamoto, Y Takano, SI Murota, and I Morita. (2003). Development of a liquid culture system for megakaryocyte terminal differentiation: fibrinogen promotes megakaryocytopoiesis but not thrombopoiesis. Br J Haematol 121:315-323.
53. McNiece IK and RA Briddell. (1995). Stem cell factor. J Leukoc Biol 58:14-22.
54. Lisovsky M, SE Braun, Y Ge, H Takahira, L Lu, VG Savchenko, SD Lyman, and HE Broxmeyer. (1996). Flt3-ligand production by human bone marrow stromal cells. Leukemia 10:1012-1018.
55. Solanilla A, J Dechanet, A El Andaloussi, M Dupouy, F Godard, J Chabrol, P Charbord, J Reiffers, AT Nurden, B Weksler, JF Moreau, and J Ripoche. (2000). CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells. Blood 95:3758-3764.
56. + cells after allogeneic bone marrow transplantation. J Hematother 11:321-326.
57. + cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol 13:1922-1932.
58. + cells best predict platelet recovery after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 21:1217-1222.
59. Lefebvre P, JN Winter, Y Meng, and I Cohen. (2000). Ex vivo expansion of early and late megakaryocyte progenitors. J Hematother 9:913-921.
60. Kanamaru S, Y Kawano, T Watanabe, R Nakagawa, H Suzuya, T Onishi, J Yamazaki, T Nakayama, Y Kuroda, and Y Takaue. (2000). Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant. Stem Cells 18:190-195.